Sarclisa

Sarclisa (Isatuximab) is an intravenous medication used in cancer treatment. This monoclonal antibody targets specific proteins to help manage certain types of cancer. Learn more about its uses and effects.

Sarclisa is primarily used in the treatment of multiple myeloma, a type of blood cancer. It works by targeting CD38, a protein found on the surface of myeloma cells. This medication is often used in combination with other treatments to help manage the disease. Patients and healthcare providers may discuss 'what is Sarclisa used for' to understand its role in cancer therapy.

Common effects of Sarclisa may include infusion-related reactions such as fever, chills, and fatigue. Some patients may also experience nausea, diarrhea, or an increased risk of infections. These effects can vary from person to person and should be discussed with a healthcare professional.

Sarclisa should be administered under the supervision of a healthcare professional. Patients should be monitored for signs of infusion reactions and infections. It is important to follow all safety guidelines provided by the healthcare provider to ensure safe use.

Sarclisa may interact with other medications, including those that suppress the immune system. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Alcohol and certain foods may also affect how Sarclisa works.